Murphy & Mullick Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$52.9K Hold
596
– – 0.03% 288
2026
Q2
$51.3K Sell
596
-316
-35% -$27.7K 0.03% 291
2026
Q1
$82.5K Hold
912
– – 0.06% 219
2025
Q4
$82K Sell
912
-430
-32% -$40.8K 0.06% 217
2025
Q3
$132K Hold
1,342
– – 0.1% 173
2025
Q2
$123K Hold
1,342
– – 0.1% 166
2025
Q1
$152K Hold
1,342
– – 0.15% 143
2024
Q4
$142K Buy
+1,342
New +$144K 0.13% 149

Other funds holding ZBH

Murphy & Mullick Capital Management's ZBH Position: Q3 2026 in Review

Murphy & Mullick Capital Management held its Zimmer Biomet (ZBH) position steady in Q3 2026 at 596 shares worth $52.9K. The position accounts for 0.03% of the portfolio, ranked #288.

Murphy & Mullick Capital Management first reported a position in ZBH in Q4 2024 and has held it in 8 quarters since. The position peaked at $152K in Q1 2025. 478 funds tracked by Wall St. Rank hold ZBH as of Q3 2026.

  • Murphy & Mullick Capital Management held 596 shares of Zimmer Biomet worth $52.9K as of Q3 2026.
  • Murphy & Mullick Capital Management left its Zimmer Biomet share count unchanged in Q3 2026.
  • Zimmer Biomet made up 0.03% of Murphy & Mullick Capital Management's portfolio in Q3 2026, its #288 holding.
  • Murphy & Mullick Capital Management first reported a position in Zimmer Biomet in Q4 2024 and has held it in 8 quarters since.
  • Murphy & Mullick Capital Management's Zimmer Biomet position peaked at $152K in Q1 2025.
  • 478 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.